These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 12833454)
1. Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer. Dykes SL; Qui H; Rothenberger DA; García-Aguilar J Cancer; 2003 Jul; 98(1):48-54. PubMed ID: 12833454 [TBL] [Abstract][Full Text] [Related]
2. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Lawes DA; Pearson T; Sengupta S; Boulos PB Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253 [TBL] [Abstract][Full Text] [Related]
3. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982 [TBL] [Abstract][Full Text] [Related]
4. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E Digestion; 2004; 69(3):166-76. PubMed ID: 15118395 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer. Velayos FS; Lee SH; Qiu H; Dykes S; Yiu R; Terdiman JP; Garcia-Aguilar J J Gastrointest Surg; 2005 Mar; 9(3):329-35. PubMed ID: 15749592 [TBL] [Abstract][Full Text] [Related]
8. [Is immunohistochemistry for MLH1 and MSH2 proteins a useful method for detection of microsatellite instability in sporadic colorectal cancer?]. Do JH; Chang SK; Ahnn JY; Cha BK; Cheong SM; Kim DW; Cheong HR; Kim HJ; Kim JG; Lee TJ; Park ES; Park SM Korean J Gastroenterol; 2003 Nov; 42(5):369-76. PubMed ID: 14646573 [TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088 [TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma. Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042 [TBL] [Abstract][Full Text] [Related]
11. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Simpkins SB; Bocker T; Swisher EM; Mutch DG; Gersell DJ; Kovatich AJ; Palazzo JP; Fishel R; Goodfellow PJ Hum Mol Genet; 1999 Apr; 8(4):661-6. PubMed ID: 10072435 [TBL] [Abstract][Full Text] [Related]
12. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503 [TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488 [TBL] [Abstract][Full Text] [Related]